This cohort study investigates whether semaglutide prescription is associated with increased risk of nonarteritic anterior ischemic optic neuropathy among patients with type 2 diabetes and patients who are overweight or obese.| jamanetwork.com
This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastrointestinal adverse events.| jamanetwork.com